首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1619553篇
  免费   132115篇
  国内免费   2665篇
耳鼻咽喉   21780篇
儿科学   53173篇
妇产科学   46507篇
基础医学   230137篇
口腔科学   47647篇
临床医学   142018篇
内科学   319220篇
皮肤病学   34346篇
神经病学   131622篇
特种医学   65437篇
外国民族医学   474篇
外科学   246647篇
综合类   39797篇
现状与发展   3篇
一般理论   545篇
预防医学   123342篇
眼科学   36967篇
药学   122645篇
  3篇
中国医学   3035篇
肿瘤学   88988篇
  2018年   15042篇
  2016年   13196篇
  2015年   15317篇
  2014年   21039篇
  2013年   31851篇
  2012年   43342篇
  2011年   45589篇
  2010年   26806篇
  2009年   25683篇
  2008年   43732篇
  2007年   46004篇
  2006年   46749篇
  2005年   45417篇
  2004年   44910篇
  2003年   42931篇
  2002年   42055篇
  2001年   76376篇
  2000年   79036篇
  1999年   67057篇
  1998年   17976篇
  1997年   16517篇
  1996年   16470篇
  1995年   16164篇
  1994年   15210篇
  1993年   14337篇
  1992年   55911篇
  1991年   54191篇
  1990年   52969篇
  1989年   51262篇
  1988年   47584篇
  1987年   46875篇
  1986年   44582篇
  1985年   43167篇
  1984年   32250篇
  1983年   27729篇
  1982年   16218篇
  1981年   14496篇
  1980年   13611篇
  1979年   30607篇
  1978年   21170篇
  1977年   17868篇
  1976年   16761篇
  1975年   17633篇
  1974年   21565篇
  1973年   20747篇
  1972年   18940篇
  1971年   17859篇
  1970年   16368篇
  1969年   15335篇
  1968年   14040篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Background: Gait disorders are common in Parkinson’s disease patients who respond poorly to dopaminergic treatment. Blockade of adenosine A2A receptors is expected to improve gait disorders. Istradefylline is a first-in-class selective adenosine A2A receptor antagonist with benefits for motor complications associated with Parkinson’s disease.

Research design and methods: This multicenter, open-label, single-group, prospective interventional study evaluated changes in total gait-related scores of the Part II/III Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Freezing of Gait Questionnaire (FOG-Q) in 31 Parkinson’s disease patients treated with istradefylline. Gait analysis by portable gait rhythmogram was performed.

Results: MDS-UPDRS Part III gait-related total scores significantly decreased at Weeks 4–12 from baseline with significant improvements in gait, freezing of gait, and postural stability. Significant decreases in MDS-UPDRS Part II total scores and individual item scores at Week 12 indicated improved daily living activities. At Week 12, there were significant improvements in FOG-Q, new FOG-Q, and overall movement per 48 h measured by portable gait rhythmogram. Adverse events occurred in 7/31 patients.

Conclusions: Istradefylline improved gait disorders in Parkinson’s disease patients complicated with freezing of gait, improving their quality of life. No unexpected adverse drug reactions were identified.

Trial registration: UMIN-CTR (UMIN000020288).  相似文献   

2.

Objectives

Expedient extubation after cardiac surgery has been associated with improved outcomes, leading to postoperative extubation frequently during overnight hours. However, recent evidence in a mixed medical-surgical intensive care unit population demonstrated worse outcomes with overnight extubation. This study investigated the impact of overnight extubation in a statewide, multicenter Society of Thoracic Surgeons database.

Methods

Records from 39,812 patients undergoing coronary artery bypass grafting or valve operations (2008-2016) and extubated within 24 hours were stratified according to extubation time between 06:00 and 18:00 (day) or between 18:00 and 6:00 (overnight). Outcomes including reintubation, mortality, and composite morbidity-mortality were evaluated using hierarchical regression models adjusted for Society of Thoracic Surgeons predictive risk scores. To further analyze extubation during the night, a subanalysis stratified patients into 3 groups: 06:00 to 18:00, 18:00 to 24:00, and 24:00 to 06:00.

Results

A total of 20,758 patients were extubated overnight (52.1%) and were slightly older (median age 66 vs 65 years, P < .001) with a longer duration of ventilation (4 vs 7 hours, P < .001). Day and overnight extubation were associated with equivalent operative mortality (1.7% vs 1.7%, P = .880), reintubation (3.7% vs 3.4%, P = .141), and composite morbidity-mortality (8.2% vs 8.0%, P = .314). After risk adjustment, overnight extubation was not associated with any difference in reintubation, mortality, or composite morbidity-mortality. On subanalysis, those extubated between 24:00 and 06:00 exhibited increased composite morbidity-mortality (odds ratio, 1.18; P = .001) but no difference in reintubation or mortality.

Conclusions

Extubation overnight was not associated with increased mortality or reintubation. These results suggest that in the appropriate clinical setting, it is safe to routinely extubate cardiac surgery patients overnight.  相似文献   
3.
4.
5.
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号